Lab Interpretation
Gut Bacteria Markers on the Organic Acids Test: A Practitioner's Interpretation Guide
What the yeast, Clostridia and dysbiosis markers on the Organic Acids Test measure, what the evidence behind each one shows, and why they need confirmation before any treatment decision.
The gut bacteria and yeast markers on the Organic Acids Test (OAT) are urine metabolites of gut microbes, and a review of urinary organic acids lists benzoate, hippurate, phenylacetate, phenylpropionate, cresol, indican, D-lactate and D-arabinitol among them. They suggest what microbes may be doing metabolically, and they work best read as a pattern and confirmed with stool or breath testing before any treatment decision.
→ Pillar: Organic Acids Test
What are the gut bacteria markers on the Organic Acids Test?
The OAT does not identify microorganisms directly. It measures microbial metabolites, because products of intestinal microbial metabolism can be absorbed and excreted in urine.
The markers usually fall into three groups:
- Yeast markers, such as arabinose and tartaric acid
- Clostridia markers, such as HPHPA and 4-cresol
- General dysbiosis markers, such as phenolic compounds from bacterial fermentation
Pattern recognition across the section is more useful than flagging a single outlier, and no single marker is diagnostic.
What do yeast markers on the OAT mean?
Arabinose is the headline yeast marker on the OAT. The early evidence is thin. Shaw and colleagues reported high urinary arabinose, along with tartaric and citramalic acids, in two brothers with autistic features.
A related marker, the urine D-arabinitol/L-arabinitol ratio, has had mixed performance. In patients with blood cancers or HIV, the ratio was elevated in only 5 of 10 patients with proven invasive candidiasis and in 1 of 15 HIV patients with oral or esophageal candidiasis.
Tartaric acid is the other yeast marker commonly reported with arabinose, and it appeared in the same two-brother report.
An isolated borderline yeast marker in a patient without matching symptoms needs clinical correlation before any treatment decision.
What are the Clostridia markers on the OAT?
HPHPA and 4-cresol are the most discussed Clostridia markers. A single-author review by Shaw proposes that Clostridia metabolites such as HPHPA and 4-cresol inhibit dopamine beta hydroxylase, and links them to autism. That hypothesis rests largely on pediatric autism literature and has not been confirmed by independent clinical trials.
Some practitioners look at these markers when mood or behavioral symptoms come with gut complaints. The evidence for that use is limited, and the result is one piece of the picture.
What are OAT dysbiosis markers?
The 2008 review of urinary dysbiosis markers describes several organic acids as products of bacterial metabolism of dietary polyphenols or unabsorbed amino acids and carbohydrates. Markers it lists include:
- Benzoate and hippurate
- Phenylacetate and phenylpropionate
- Cresol and related hydroxyphenyl compounds
- Indican
- D-lactate
When several of these are elevated together, the pattern is more informative than any single value. Which follow-up test to order is a decision for the treating clinician.
How is the OAT different from stool testing for gut bacteria?
Stool testing identifies organisms directly, while the OAT reports their urinary metabolites. A useful way to think about it: OAT microbial markers suggest a hypothesis, and stool or breath testing helps identify the organism. For stool interpretation, see Reading Your GI-MAP Results. An elevated indican may prompt a SIBO workup, covered in SIBO Treatment Protocols.
Universal principle: OAT microbial markers are functional signals. No treatment decision should rest on the OAT alone, and the specific agents, doses, order and retest timing are decisions for the treating clinician.
Practical Takeaways
- Arabinose is the headline yeast marker, with limited published validation
- HPHPA is the most discussed Clostridia marker, and its proposed link to mood symptoms rests on a single-author hypothesis
- The OAT measures what microbes may be doing: use it to generate hypotheses and guide confirmatory testing
- Clusters matter more than single markers
- Retesting can document change over time, on a schedule the treating clinician sets
References
- Shaw W, Kassen E, Chaves E. Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chem. 1995, 41(8):1094-1104. PMID 7628083
- Eisen DP, et al. Urine D-arabinitol/L-arabinitol ratio in diagnosing Candida infection in patients with haematological malignancy and HIV infection. Diagn Microbiol Infect Dis. 2002, 42(1):39-42. PMID 11821170
- Shaw W. Inhibition of the beta-oxidation pathway of fatty acids and dopamine beta hydroxylase by phenyl derivatives of short-chain fatty acids from gastrointestinal Clostridia bacteria is a (the) major cause of autism. Integr Med (Encinitas). 2023, 22(2):18-25. PMID 37363147. Single-author hypothesis paper.
- Lord RS, Bralley JA. Clinical applications of urinary organic acids. Part 2. Dysbiosis markers. Altern Med Rev. 2008, 13(4):292-306. PMID 19152477
Related Articles
- OAT Mitochondrial Function Markers Explained
- Oxalates and Detoxification on OAT
- Reading Your GI-MAP Results
- GI-MAP Dysbiosis Treatment Protocols
- Leaky Gut Syndrome Treatment
Ready to Spend Less Time on OAT Documentation?
HANS is a clinical AI copilot that runs beside your EMR. It structures OAT results, GI-MAP findings and DUTCH panels into your notes so you can spend your time interpreting.